Efficacy and safety of vilazodone in patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled, flexible-dose trial
OPEN The Journal of clinical psychiatry | 28 May 2016
S Durgam, C Gommoll, G Forero, R Nunez, X Tang, M Mathews and DV Sheehan
To evaluate the efficacy, safety, and tolerability of vilazodone as an acute treatment for generalized anxiety disorder (GAD). Vilazodone is a selective serotonin reuptake inhibitor and 5-HT1A receptor partial agonist approved for the treatment of major depressive disorder in adults.
* Data courtesy of Altmetric.com